An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer

International Journal of Oncology

Volumn 36, Issue 2, 2010, Pages 405-414

  Zhang, Xianglan ^a   Yang, Jung Jin ^b   Kim, Yoon Sun ^b   Kim, Ki Yeol ^c   Ahn, Woong Shick ^b   Yang, Sanghwa ^a  

^a Yonsei University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Yonsei University College of Dentistry   (South Korea)

Author keywords

Biomarker; Gastric cancer; Gene expression profiling; Methylation

Indexed keywords

CHROMOGRANIN A; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 3; INHIBIN A; KRUPPEL LIKE FACTOR 4; SOMATOSTATIN; THY 1 ANTIGEN; TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MALE; MELANOMA; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; SERPINH1 GENE; STOMACH CANCER; THYROID CANCER; TISSUE MICROARRAY; TUMOR GENE; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, THY-1; CHROMOGRANIN A; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION PROFILING; GLUTATHIONE PEROXIDASE; HSP47 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBIN-BETA SUBUNITS; KAPLAN-MEIERS ESTIMATE; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIPASE; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOMATOSTATIN; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 75449099529     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000513     Document Type: Article

References (38)

1. Parkin D M, Bray F and Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Yang S: Gene amplifications at chromosome 7 of the human gastric cancer genome. Int J Mol Med 20: 225-231, 2007.
3. Yang S and Chung H: Novel biomarker candidates for gastric cancer. Oncol Rep 19: 675-680, 2008.
4. Yang S, Shin J, Park KH, Jeung H-C, Rha SY, Noh SH, Yang WI and Chung HC: Molecular basis of the differences between normal and tumor tissues of gastric cancer. Biochim Biophys Acta 1772: 1033-1040, 2007.
5. Yang SH, Seo MY, Jeong HJ, Jeung H-C, Shin J, Kim SC, Noh SH, Chung H and C and Rha SY: Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients. Clin Cancer Res 11: 612-620, 2005.
6. Dupuy A and Simon RM: Critical review of published micro-array studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 99: 147-157, 2007.
7. Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong J-M, Fukayama M and Kodama T and Aburatani H: Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 62: 233-240, 2002.
8. Li L-C and Dahiya R: Methprimer: designing primers for methylation pcrs. Bioinformatics 18: 1427-1431, 2002.
9. Schmid CD, Perier R and Praz V and Bucher P: EPD in its twentieth year: towards complete promoter coverage of selected model organisms. Nucl Acids Res 34: D82-D85, 2006.
10. Witton C, Hawe S and Cooke T and Bartlett J: Cyclooxygenase 2 (Cox2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Histopathology 45: 47-54, 2004.
11. Yang S, Jeung H-C, Jeong HJ, Choi YH, Kim JE, Jung J-J, Rha SY, Yang WI and Chung HC: Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer. Genomics 89: 451-459, 2007.
12. Esteller M: Epigenetics in cancer. N Engl J Med 358: 1148-1159, 2008.
13. Su AI, Welsh J B, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, Schultz PG, Powell SM, Moskaluk CA, Frierson HF Jr and Hampton GM: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61: 7388-7393, 2001.
14. Yu YP, Yu G, Tseng G, Cieply K, Nelson J, Defrances M, Zarnegar R and Michalopoulos G and Luo J-H: Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 67: 8043-8050, 2007.
15. Lee O-J, Schneider-Stockz R, McChesney PA, Kuester D, Albert Roessnerz, Vieth M, Moskalukb CA and El-Rifai W: Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Neoplasia 7: 854-861, 2005.
16. Lodygin D, Epanchintsev A, Menssen A, Diebold J and Hermeking H: Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65: 4218-4227, 2005.
17. Schmutzler C, Mentrup B, Schomburg L, Hoang-Vu C, Herzog V and Köhrle J: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol Chem 388: 1053-1059, 2007.
18. Mori Y, Cai K, Cheng Y, Wang S, Paun B, Hamilton JP, Jin Z, Sato F, Berki AT, Kan T, Ito T, Mantzur C, Abraham JM and Meltzer SJ: A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 131: 797-808, 2006.
19. Colucci R, Blandizzi C, Ghisu N, Florio T and Del Tacca M: Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation. Br J Pharmacol 155: 198-209, 2008.
20. Jin Z, Mori Y, Hamilton J, Olaru A, Sato F, Yang J, Ito T, Kan T, Agarwal R and Meltzer S: Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis. Cancer 112: 43-49, 2008.
21. Ongenaert M, Wisman G, Volders H, Koning A, van der Zee A and van Criekinge W and Schuuring E: Discovery of DNA methylation markers in cervical cancer using relaxation ranking. BMC Med Genomics 1: 57, 2008.
22. Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, Wu T-T, Huang S and Xie K: Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 65: 2746-2754, 2005.
23. Wei D, Kanai M, Huang S and Xie K: Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 27: 23-31, 2006.
24. Yasunaga J-I, Taniguchi Y, Nosaka K, Yoshida M, Satou Y, Sakai T, Mitsuya H and Matsuoka M: Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res 64: 6002-6009, 2004.
25. Zhao W, Hisamuddin I, Nandan M, Babbin B, Lamb N and Yang V: Identification of krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23: 395-402, 2004.
26. Chiu S-T, Hsieh F-J, Chen S-W, Chen C-L, Shu H-F and Li H: Clinicopathologic correlation of up-regulated genes identified using cdna microarray and real-time reverse transcription-PCR in human colorectal cancer. Cancer Epidemiol Biomarkers Prev 14: 437-443, 2005.
27. Lung HL, Bangarusamy DK, Xie D, Cheung AKL, Cheng Y, Kumaran MK, Miller L, Liu ET-B, Guan X-Y, Sham JS, Fang Y, Li L, Wang N, Protopopov AI, Zabarovsky ER, Tsao SW, Stanbridge EJ and Lung ML: Thy1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene 24: 6525-6532, 2005.
28. Cao D, Hustinx SR, Sui G, Bala P, Sato N, Martin S, Maitra A, Murphy KM, Cameron JL, Yeo CJ, Kern SE, Goggins M, Pandey A and Hruban RH: Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags. Cancer Biol Ther 3: 1081-1089, 2004.
29. Ye H, Yu T, Temam S, Ziober B, Wang J, Schwartz J, Mao L, Wong D and Zhou X: Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 9: 69, 2008.
30. Iacobuzio-Donahue C, Maitra A, Shen-Ong G L, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M and Hruban RH: Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 160: 1239-1249, 2002.
31. Maitra A, Iacobuzio-Donahue C, Rahman A, Sohn T, Argani P, Meyer R, Yeo C, Cameron J, Goggins M, Kern S, Ashfaq R, Hruban R and Wilentz R: Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: Sea urchin fascin homolog and heat shock protein 47. Am J Clin Pathol 118: 52-59, 2002.
32. Peng DF, Razvi M, Chen H, Washington K, Roessner A, Schneider-Stock R and El-Rifai W: DNA hypermethylation regulates the expression of members of the mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut 58: 5-15, 2009.
33. Scotto L, Narayan G, Nandula S, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann A, Wright J, Pothuri B and Mansukhani M: Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression. Genes Chromosomes Cancer 47: 755-765, 2008.
34. Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, Ondrey FG, Adams GL and Gaffney PM: Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 64: 55-63, 2004.
35. Stearman R, Dwyer-Nield L, Zerbe L, Blaine S, Chan Z, Bunn P, Johnson G, Hirsch F, Merrick D and Franklin W: Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol 167: 1763-1775, 2005.
36. Talantov D, Mazumder A, Yu J, Briggs T, Jiang Y, Backus J, Atkins D and Wang Y: Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 11: 7234-7242, 2005.
37. Carr IM, Valleley EMA, Cordery SF, Markham AF and Bonthron DT: Sequence analysis and editing for bisulphite genomic sequencing projects. Nucl Acids Res 35: e79, 2007.
38. Rozen S and Skaletsky H: Primer3 on the www for general users and for biologist programmers. Methods Mol Biol 132: 365-386, 2000.